[1]郭文慧,原 景,张 炜.益气活血化痰方治疗慢性阻塞性肺疾病稳定期疗效研究[J].陕西中医,2021,(6):721-723,738.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.010]
　GUO Wenhui,YUAN Jing,ZHANG Wei.Efficacy of Yiqi Huoxue Huatan recipe on patients with chronic obstructive pulmonary disease in stable stage[J].,2021,(6):721-723,738.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.010]
点击复制

益气活血化痰方治疗慢性阻塞性肺疾病稳定期疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年6期
页码:
721-723,738
栏目:
临床研究
出版日期:
2021-06-05

文章信息/Info

Title:
Efficacy of Yiqi Huoxue Huatan recipe on patients with chronic obstructive pulmonary disease in stable stage
作者:
郭文慧; 原 景; 张 炜
(北京中医药大学附属护国寺中医医院内科,北京 100035)
Author(s):
GUO Wenhui; YUAN Jing; ZHANG Wei
(Department of Internal Medicine,Huguosi Hospital of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100035,China)
关键词:
慢性阻塞性肺疾病;  气虚痰瘀证;  益气活血化痰方;  肺功能;  生活质量
Keywords:
Chronic obstructive pulmonary disease;  Qixu Tanyu syndrome;  Yiqi Huoxue Huatan recipe;  Lung function;  Quality of life
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7369.2020.06.010
文献标志码:
A
摘要:
目的:探讨益气活血化痰方治疗慢性阻塞性肺疾病(COPD)稳定期气虚痰瘀证的临床疗效。方法:选取80例COPD稳定期气虚痰瘀证患者,随机分为对照组40例、治疗组40例。对照组给予羧甲司坦片联合噻托溴铵粉吸入粉雾剂治疗,治疗组在对照组基础上给予益气活血化痰方。比较两组临床疗效、中医症状评分、改良英国医学研究会呼吸困难指数(mMRC)评分、COPD评估测试(CAT)、肺功能、血气指标、不良反应。结果:治疗后,两组患者中医症状评分、mMRC评分、CAT均较治疗前下降,且治疗组低于对照组(均P<0.05)。治疗后,两组患者FEV1、FVC、FEV1/FVC均较治疗前升高,且治疗组水平高于对照组(均P<0.05)。治疗后,两组患者PaO2、SaO2均较治疗前升高,PaCO2较治疗前降低,治疗组PaO2、SaO2水平高于对照组(均P<0.05)。治疗组总有效率95.00%高于对照组的77.50%(P<0.05)。结论:益气活血化痰方治疗COPD稳定期气虚痰瘀证患者疗效较好,可增强肺功能、改善患者生活质量。
Abstract:
Objective:To study the clinical effect of Yiqi Huoxue Huatan decoction in treating stable stage of chronic obstructive pulmonary disease(COPD)of Qixu Tanyu type.Methods:80 patients with COPD stable stage of Qixu Tanyu type were randomly divided into control group 40 cases and treatment group 40 cases.The control group was treated with carboxymethyl stann tablet combined with tiotropium bromide powder inhalation powder aerosol,and the treatment group was treated with Yiqi Huoxue Huatan recipe on the basis of the control group.The clinical efficacy,TCM symptom score,modified British medical research council(mMRC)score,COPD assessment test(CAT),pulmonary function index and blood gas index,adverse reactions were compared between the two groups.Results:After treatment,the TCM symptom score,mMRC score and CAT of the two groups decreased,and the treatment group were lower than the control group(all P<0.05).After treatment,The FEV1,FVC,FEV1/FVC of the two groups were higher than those before treatment,and the treatment group were higher than the the control group(all P<0.05).After treatment,the PaO2,SaO2 of the two groups were higher than those before treatment,the PaCO2 was lower than that before treatment,and the PaO2,SaO2 of the treatment group were higher than those of the control group(all P<0.05).The total effective rate of the treatment group was 95.00% significantly higher than 77.50% of the control group(P<0.05).Conclusion:Yiqi Huoxue Huatan recipehas good effect on patients with COPD in stable period of Qixu Tanyu type,which can enhance lung function and improve the quality of life of patients.

参考文献/References:

[1] 费建荣,朱佳威.活血祛瘀化痰法对慢性阻塞性肺疾病伴肺心病患者高凝血状态及心肺功能的影响[J].中国生化药物杂志,2017,37(6):129-130.
[2] Bhatt SP,Soler X,Wang X,et al.Association between functional small airways disease and FEV1 decline in COPD[J].Am J Respir Crit Care Med,2016,194(2):178.
[3] 金 晶,秦慧娟.益气活血化痰方联合小剂量阿托伐他汀对高危性COPD患者动脉僵硬度、血液黏度及预后的影响研究[J].重庆医学,2017,46(28):3943-3946.
[4] 陈云坤,冯英凯.GOLD 2017新版指南要点解读[J].现代医药卫生,2017,33(4):481-483.
[5] 孙增涛,张文娟,杨建宇,等.肺胀诊疗指南[J].中国中医药现代远程教育,2011,9(12):118-119.
[6] 国家中医药管理局.中医病症诊断疗效标准[M].南京:南京大学出版社,2002,4(15):238-240.
[7] 释涤凡.益气养阴化痰活血法治疗气阴两虚、痰瘀伏肺型慢性阻塞性肺疾病稳定期患者的临床疗效评价[J].山西医药杂志,2017,46(23):2888-2890.
[8] 刘 娟,王 军,邓庆华.慢性阻塞性肺疾病炎症机制及中药单体成分对其治疗作用的研究进展[J].中国药房,2018,29(8):1145-1149.
[9] Cochair WJ,Miravitlles M,Hurst JR,et al.Management of COPD exacerbations:A European respiratory society/American thoracic society guideline[J].European Respiratory Journal,2017,49(3):160-167.
[10] 俞茹云,胡 瑶,陈宝华,等.黄芪对慢性阻塞性肺疾病急性加重期患者细胞因子的影响[J].重庆医学,2018,47(28):3712-3713,3715.
[11] 赖 乾,李 娟,李金田,等.基于中医传承辅助平台的中医药治疗慢性阻塞性肺疾病的用药规律分析[J].中国老年学杂志,2017,37(16):4019-4021.
[12] 纪 利,陈 炜.浅谈中西医肺康复在慢性阻塞性肺疾病稳定期中的治疗进展[J].中国中医急症,2017,26(3):470-472.
[13] 潘玲玲,王海英,刘 霞.中西医结合治疗老年慢性阻塞性肺疾病疗效Meta分析[J].中国老年学杂志,2015,35(21):6177-6179.
[14] 孙国华,吕纪玲,刘宝良,等.中西医结合治疗对缓解期慢性阻塞性肺疾病患者细胞因子的影响及疗效观察[J].实用医学杂志,2014,30(1):19-22.
[15] 姜轶飞,杨 猛,莫伟强.慢性阻塞性肺疾病评估测试评分对AECOPD患者的临床评估价值[J].中国中西医结合急救杂志,2017,24(2):174-176,216.
[16] 李国宏,廖 莉.羧甲司坦辅助治疗稳定期慢性阻塞性肺疾病观察[J].药物流行病学杂志,2017,26(7):456-459.
[17] 罗 柱,刘春涛,吴昌归,等.国产噻托溴铵干粉剂治疗慢性阻塞性肺疾病的多中心随机对照临床试验[J].四川大学学报:医学版,2015,46(3):485-487.
[18] 陈 新.益气疏肝化痰活血法治疗慢性阻塞性肺疾病合并焦虑障碍研究进展[J].中医学报,2016,31(12):1859-1862.
[19] Dilektasli AG,Porszasz J,Casaburi R,et al.A novel spirometric measure identifies mild COPD unidentified by standard criteria[J].Chest,2016,150(5):1080-1090.
[20] 闵 婕,毛 兵,蒋红丽,等.益气活血法治疗慢性阻塞性肺疾病稳定期(气虚血瘀证)的临床研究[J].四川大学学报:医学版,2014,45(4):601-605.

相似文献/References:

[1]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[2]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
　WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(6):610.
[3]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995.
　LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(6):995.
[4]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
　WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(6):1491.
[5]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57.
　REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(6):57.
[6]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(6):180.
[7]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[8]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534.
　DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(6):534.
[9]季学清,刘 萍△,陈宝瑾,等.冠心康方加减联合西药治疗冠心病合并2型糖尿病气虚痰瘀证疗效研究*[J].陕西中医,2020,(9):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
　JI Xueqing,LIU Ping,CHEN Baojin,et al.Efficacy of Guanxinkang preparation combined with western medicine in the treatment of coronary heart disease and type 2 diabetes mellitus with syndrome of Qixu Tanyu[J].,2020,(6):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
[10]唐颖丽,谢 珊,余清萍,等.子午流注法治疗慢性阻塞性肺疾病加重期痰浊阻肺证疗效研究*[J].陕西中医,2020,(9):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
　TANG Yingli,XIE Shan,YU Qingping,et al.Curative effect of midnight-noon ebb-flow method on chronic obstructive pulmonary disease exacerbation with syndrome of Tanzhuo Zufei[J].,2020,(6):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]

备注/Memo

备注/Memo:
基金项目:北京市科学技术委员会项目(Q1151556)
更新日期/Last Update: 2021-06-09